These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1550700)

  • 1. Does smoking influence the pharmacokinetics and pharmacodynamics of the H2-receptor antagonist famotidine?
    Baak LC; Ganesh S; Jansen JB; Lamers CB
    Br J Clin Pharmacol; 1992 Feb; 33(2):193-6. PubMed ID: 1550700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
    Bisson C; St-Laurent M; Michaud JT; LeBel M
    Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and pH response to H2-receptor antagonists.
    Schürer-Maly CC; Varga L; Koelz HR; Halter F
    Scand J Gastroenterol; 1989 Dec; 24(10):1172-8. PubMed ID: 2690314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics and dose-response relationship of famotidine: a double-blind randomized placebo-controlled trial.
    Laskin OL; Patterson PM; Shingo S; Lasseter KC; Shamblen EC
    J Clin Pharmacol; 1993 Jul; 33(7):636-9. PubMed ID: 8366188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of famotidine in infants.
    James LP; Marotti T; Stowe CD; Farrar HC; Taylor BJ; Kearns GL
    J Clin Pharmacol; 1998 Dec; 38(12):1089-95. PubMed ID: 11301560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of famotidine in children with gastroduodenal ulcers.
    Nagita A; Manago M; Aoki S; Mino M; Suzuki K; Ashida K
    Ther Drug Monit; 1994 Oct; 16(5):444-9. PubMed ID: 7846741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
    Feldman M
    JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
    Merki HS; Witzel L; Kaufman D; Kempf M; Neumann J; Röhmel J; Walt RP
    Gut; 1988 Apr; 29(4):453-7. PubMed ID: 3286384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragastric long-term pH-metry in hemodialysis patients. A study with famotidine.
    Gladziwa U; Wagner S; Dakshinamurty KV; Bechtel B; Mann H; Sieberth HG
    Clin Nephrol; 1991 Aug; 36(2):97-102. PubMed ID: 1934666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis.
    Gladziwa U; Wagner S; Dakshinamurty KV; el Desoky E; Dreuw B; Klotz U
    Eur J Clin Pharmacol; 1993; 44(4):357-60. PubMed ID: 8513846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a 28-day therapy with famotidine on blood levels of alcohol and gastrin and intragastric pH in healthy human subjects.
    Teyssen S; Chari ST; Joos A; Singer MV
    Scand J Gastroenterol; 1994 May; 29(5):398-405. PubMed ID: 8036454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and pharmacodynamics of two morphologically homogenous forms of famotidine per os in Chinese healthy volunteers].
    Liu GL; Gao S; Wang SX; Shen WJ; Tan JQ
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):257-9. PubMed ID: 8237405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
    Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
    Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.